4.4 Article

Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patients

期刊

AIDS
卷 29, 期 16, 页码 2099-2108

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QAD.0000000000000807

关键词

HIV-infection; non-AIDS-defining comorbidities; T-cell differentiation; T-cell immune activation; T-cell immune senescence

资金

  1. Agence nationale de recherches sur le sida et les hepatites virales (ANRS) [7]
  2. ViiV
  3. Janssen
  4. MSD

向作者/读者索取更多资源

Objectives: We studied the link between T-cell activation, differentiation and senescence phenotypes and non-AIDS-related comorbidities in HIV-suppressed patients. Design: Patients included in the ANRS CO3 Aquitaine Cohort were consecutively enrolled in this cross-sectional study between October 2011 and May 2013 called Chronic Immune Activation and Senescence (CIADIS) study. Methods: We summarized immune markers [CD4(+) and CD8(+) activation (DR+), differentiation (naive and terminally differentiated memory T cells), and senescence (CD57(+)CD28(-))] in a weighted immune score by principal component analysis called CIADIS. Previously described Veterans Aging Cohort Study (VACS) index and immune risk profile (IRP) scores were calculated. We used adjusted logistic regression to assess the association between the CIADIS score and the presence of at least three non-AIDS-defining comorbidities. Results: Of 876 patients with an undetectable viral load, 73.4% were men and median age was 50.5 years [interquartile range (IQR) 44.7-56.7 years]. Median CD4(+) T-cell count was 579/mu l (IQR 429-759cells/mu l), and median duration of HIV viral suppression was 5.3 years (IQR 2.3-8.7). The weighted CIADIS score was associated with at least three comorbidities (odds ratio 1.3 for 1 SD more, 95% confidence interval 1.0, 1.6) independently of age, sex, AIDS stage, and the Veterans Aging Cohort Study score. The CIADIS and the immune risk profile scores were significantly associated with at least three comorbidities in adjusted models restricted to patients younger than 60 years. None of the tested scores were associated with at least three comorbidities in patients older than 60 years. Conclusions:The weighted CIADIS score based on activation, senescence, and differentiation markers might help physicians identifying patients at a higher risk for non-AIDS-related comorbidities. Copyright (c) 2015 Wolters Kluwer Health, Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus

Boun Kim Tan, Mathieu Chalouni, Dominique Salmon Ceron, Alexandre Cinaud, Laure Esterle, Marc Arthur Loko, Christine Katlama, Isabelle Poizot-Martin, Didier Neau, Julie Chas, Philippe Morlat, Eric Rosenthal, Karine Lacombe, Alissa Naqvi, Karl Barange, Olivier Bouchaud, Anne Gervais, Caroline Lascoux-Combe, Daniel Garipuy, Laurent Alric, Cecile Goujard, Patrick Miailhes, Hugues Aumaitre, Claudine Duvivier, Anne Simon, Jose-Luis Lopez-Zaragoza, David Zucman, Francois Raffi, Estibaliz Lazaro, David Rey, Lionel Piroth, Francois Boue, Camille Gilbert, Firouze Bani-Sadr, Francois Dabis, Philippe Sogni', Linda Wittkop, Franck Boccara

Summary: HIV-HCV coinfected patients have a high incidence of ASCVD events, with traditional cardiovascular risk factors playing a significant role. Controlling cholesterol abnormalities and maintaining undetectable HIV RNA levels are essential in reducing cardiovascular risk.

CLINICAL INFECTIOUS DISEASES (2021)

Article Gastroenterology & Hepatology

Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death

Mathieu Chalouni, Stanislas Pol, Philippe Sogni, Helene Fontaine, Karine Lacombe, Jean Marc-Lacombe, Laure Esterle, Celine Dorival, Marc Bourliere, Firouze Bani-Sadr, Victor de Ledinghen, David Zucman, Dominique Larrey, Dominique Salmon, Fabrice Carrat, Linda Wittkop

Summary: The study showed that after DAA treatment, individuals coinfected with HIV/HCV had similar SVR rates and risks of liver-related deaths and events compared to those infected with HCV alone, but had a higher risk of all-cause deaths, non-liver-related deaths, and non-liver-related cancers.

JOURNAL OF HEPATOLOGY (2021)

Review Geriatrics & Gerontology

Subcutaneous Antibiotic Therapy: The Why, How, Which Drugs and When

Virgilio Hernandez-Ruiz, Emmanuel Forestier, Gaetan Gavazzi, Tristan Ferry, Nicolas Gregoire, Dominique Breilh, Marc Paccalin, Sylvain Goutelle, Claire Roubaud-Baudron

Summary: Some studies suggest that the subcutaneous route could be an alternative to intravenous administration of antibiotics, particularly for time dependent antibiotics and certain patient populations. However, clinical evidence regarding the benefits and risks of subcutaneous antibiotic administration is still scarce and of low level. Further clinical studies are needed to assess the pharmacokinetic/pharmacodynamic properties of subcutaneous antibiotic administration.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2021)

Article Immunology

Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals

N. Legrand, G. David, A. Rodallec, A. Gaultier, D. Salmon, A. Cesbron, L. Wittkop, F. Raffi, K. Gendzekhadze, C. Retiere, C. Allavena, K. Gagne

Summary: The genetic combinations of KIR/HLA affect the clearance and chronic infection conditions of NK and T cells in HIV-HCV co-infected individuals, with European subjects with spontaneous clearance characterized by specific KIR/HLA genetic features.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)

Article Infectious Diseases

Statin use and risk of severe bacterial infection in a population living with HIV: prospective cohort study of the ANRS CO3 Aquitaine Cohort 2000-2018

Eva Teruel, Marie-Anne Vandenhende, Didier Neau, Estibaliz Lazaro, Pierre Duffau, Marc-Olivier Vareil, Charles Cazanave, Adelaide Perrier, Fabien le Marec, Olivier Leleux, Fabrice Bonnet, Linda Wittkop

Summary: The study aimed to evaluate the effect of statin use on the occurrence of severe bacterial infections in people living with HIV. The results showed no effect of statins on the risk of developing severe bacterial infections or pneumonia.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Infectious Diseases

Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH)

Tangui Barre, Teresa Rojas Rojas, Karine Lacombe, Camelia Protopopescu, Isabelle Poizot-Martin, Marie Liberee Nishimwe, David Zucman, Laure Esterle, Eric Billaud, Hugues Aumaitre, Olivier Bouchaud, David Rey, Lionel Piroth, Dominique Salmon-Ceron, Linda Wittkop, Philippe Sogni, Maria Patrizia Carrieri, Lawrence Serfaty, Fabienne Marcellin

Summary: The study suggests that regular or daily cannabis use is associated with a reduced risk of elevated fatty liver index (FLI) in HIV-HCV co-infected patients.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2021)

Article Gastroenterology & Hepatology

Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community

Francis Megraud, Robin Bruyndonckx, Samuel Coenen, Linda Wittkop, Te-Din Huang, Martin Hoebeke, Lucie Benejat, Philippe Lehours, Herman Goossens, Youri Glupczynski

Summary: The study confirmed a positive correlation between macrolide and quinolone consumption in the community and corresponding H. pylori resistance in European countries. Therefore, treatment of H. pylori with clarithromycin and levofloxacin should involve susceptibility testing in most European countries before starting the treatment.
Article Virology

Ultrasensitive Detection of p24 in Plasma Samples from People with Primary and Chronic HIV-1 Infection

Caroline Passaes, Heloise M. Delagreverie, Veronique Avettand-Fenoel, Annie David, Valerie Monceaux, Asma Essat, Michaela Mueller-Trutwin, Darragh Duffy, Nathalie De Castro, Linda Wittkop, Christine Rouzioux, Jean-Michel Molina, Laurence Meyer, Constance Delaugerre, Asier Saez-Cirion

Summary: This study evaluated the feasibility of using ultra-sensitive protein detection technologies to quantify p24 in plasma samples from people with HIV-1 infection. The results showed that ultra-sensitive p24 levels correlated with HIV RNA, DNA, and CD4(+) T cells, and provided an effective means of monitoring p24 during antiretroviral treatment.

JOURNAL OF VIROLOGY (2021)

Letter Biochemistry & Molecular Biology

A French cohort for assessing COVID-19 vaccine responses in specific populations

Paul Loubet, Linda Wittkop, Eric Tartour, Beatrice Parfait, Benoit Barrou, Jean-Yves Blay, Maryvonne Hourmant, Marie Lachatre, David-Axel Laplaud, Martine Laville, Bruno Laviolle, Jean-Daniel Lelievre, Jacques Morel, Stephanie Nguyen, Jean-Philippe Spano, Benjamin Terrier, Anne Thiebaut, Jean-Francois Viallard, Francois Vrtovsnik, Xavier de Lamballerie, Odile Launay

NATURE MEDICINE (2021)

Article Immunology

Incidence of lung and human papilloma virus-associated malignancies in HIV-infected patients

Helene Chaussade, Fabien Le Marec, Gaelle Coureau, Olivier Leleux, Didier Neau, Estibaliz Lazaro, Brice Amadeo, Pierre Duffau, Helene Ferrand, Carine Courtault, Anne-Sophie Foucan, Linda Wittkop, Fabrice Bonnet

Summary: The objective of this study was to compare the incidence oflung and human papilloma virus (HPV)-related cancers between patients with HIV and the general population. The results showed that despite the advent of antiretroviral therapies, patients with HIV still have a higher risk of lung and HPV-related cancers, especially in the age group of 40-49 years.
Review Infectious Diseases

Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review

Simon Galmiche, Liem Binh Luong Nguyen, Eric Tartour, Xavier de Lamballerie, Linda Wittkop, Paul Loubet, Odile Launay

Summary: This article systematically reviews the immunogenicity, efficacy, and effectiveness of COVID-19 vaccines in immunocompromised populations. The results highlight the risk of low immunogenicity in solid organ transplant recipients and patients with hematological malignancy. Enhanced vaccine regimens may be necessary despite the lack of vaccine effectiveness data.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Article Infectious Diseases

Long-term follow-up of HIV-1 multi-drug-resistant treatment-experienced participants treated with etravirine, raltegravir and boosted darunavir: towards drug-reduced regimen? ANRS CO3 Aquitaine Cohort 2007-2018

Elsa Nyamankolly, Pantxika Bellecave, Linda Wittkop, Fabien Le Marec, Pierre Duffau, Estibaliz Lazaro, Marc-Olivier Vareil, Camille Tumiotto, Mojgan Hessamfar, Charles Cazanave, Adelaide Perrier, Olivier Leleux, Fabrice Bonnet, Didier Neau

Summary: The efficacy of the TRIO regimen in treatment-experienced HIV-1 patients was evaluated in this study. The proportion of patients experiencing virological failure at Week 24 was described, and baseline plasma viral load and genotypic susceptibility score were found to be associated with virological failure.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)

Editorial Material Gastroenterology & Hepatology

More than shots in the dark: driving vaccine efficacy in cirrhosis

Linda Wittkop, Tobias Boettler

Article Immunology

CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies

Fabienne Caby, Marguerite Guiguet, Laurence Weiss, Alan Winston, Jose M. Miro, Deborah Konopnicki, Vincent Le Moing, Fabrice Bonnet, Peter Reiss, Cristina Mussini, Isabelle Poizot-Martin, Ninon Taylor, Athanasios Skoutelis, Laurence Meyer, Cecile Goujard, Barbara Bartmeyer, Christoph Boesecke, Andrea Antinori, Eugenia Quiros-Roldan, Linda Wittkop, Casper Frederiksen, Antonella Castagna, Maria Christine Thurnheer, Veronica Svedhem, Sophie Jose, Dominique Costagliola, Murielle Mary-Krause, Sophie Grabar

Summary: The study found that in people living with HIV who were efficiently treated with combination antiretroviral therapy, a low CD4/CD8 ratio and high CD8 count were associated with an increased risk of Kaposi sarcoma and non-Hodgkin lymphoma. This association was particularly prominent in patients with a CD4 count greater than or equal to 500/mm3.

CLINICAL INFECTIOUS DISEASES (2021)

Article Public, Environmental & Occupational Health

HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study)

Tangui Barre, Patrick Mercie, Fabienne Marcellin, Laure Esterle, Claudine Duvivier, Elina Teicher, Morgane Bureau, Julie Chas, Dominique Salmon-Ceron, Philippe Sogni, Maria Patrizia Carrieri, Linda Wittkop, Camelia Protopopescu

Summary: Tobacco smoking is highly prevalent among patients co-infected with HIV and hepatitis C virus (HCV). HCV cure is associated with increased chances of tobacco smoking quit attempts (TSQA) in HIV-HCV co-infected patients, while cannabis use is linked with decreased chances of TSQA. Therefore, screening for smoking and cannabis use, as well as providing comprehensive counseling and referral to addiction services, is important for these patients.

AIDS AND BEHAVIOR (2021)

暂无数据